药物发现的目标和生物标志物探索门户网站
Bhupesh Dewangan1, Debjyoti Ray1, Yijie Ren2
1Indian Institute of Information Technology, Allahabad 211015, India.
Bioinformatics (Oxford, England)
|November 14, 2025
概括
一个新的生物信息学工具,目标和生物标志物探索门户 (TBEP),通过整合多omics数据和网络分析来加速药物发现. 它使用机器学习和大型语言模型 (LLM) 来识别新型药物标和生物标志物.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 识别新药标和生物标志物在药物开发中至关重要但具有挑战性.
- 传统的分析方法往往忽略了关键的调节蛋白.
- 为了解决这些局限性,推出了一个新的生物信息学工具TBEP.
研究的目的:
- 介绍目标和生物标志物探索门户网站 (TBEP),这是一个基于网络的工具,旨在加速药物发现.
- 整合大规模的生物医学数据与网络分析,以确定治疗点和生物标志物.
- 为研究人员提供一个直观的平台来探索复杂的生物关系.
主要方法:
- TBEP利用机器学习来整合多模式数据集 (人类遗传学,功能基因组学,蛋白质与蛋白质相互作用).
- 它采用基于云的架构,用于实时处理大规模数据.
- 一个集成的大型语言模型 (LLM) 促进了生物网络和多omics数据的自然语言探索.
主要成果:
- TBEP解读病因机制,发现新的治疗点和精确生物标志物.
- 该工具在实时中高效处理大规模数据.
- 该法学士提高了复杂的生物学关系的解释,有助于导出可操作的见解.
结论:
- TBEP提供了一个强大的框架,以加快新药标的识别.
- 网络分析,多omics数据和LLM的整合在药物发现中提供了显著的优势.
- 该工具增强了研究人员对生物见解的探索和解释.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.5K
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.8K
相关概念视频
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
Therapeutic Drug Monitoring: Drug Analysis Methods
168
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
168
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
